Rheumatoid arthritis is a risk factor for dry eye in the Indian population

Ophthalmic Epidemiology

Volumn 13, Issue 6, 2006, Pages 379-384

  Punjabi, Omar S ^a,b,c   Adyanthaya, Rohit S ^a   Mhatre, Ashwini D ^a   Jehangir, R P ^a  

^a KEM HOSPITAL   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

Dry eye; India; Rheumatoid arthritis; Schirmer test; Tear film breakup time

Indexed keywords

FLUORESCEIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DRY EYE; EYE; FEMALE; HOSPITAL; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SCHOOL; OPHTHALMOLOGY; POPULATION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RISK FACTOR; SCHIRMER TEST; SEX; SLIT LAMP; STAINING; STATISTICAL SIGNIFICANCE; SYMPTOM; TEAR FILM;

ADULT; AGE DISTRIBUTION; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; DRY EYE SYNDROMES; FEMALE; HUMANS; INCIDENCE; INDIA; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 33845755711     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580600745969     Document Type: Article

References (30)

1. Lemp MA. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;21:221-232.
2. Patel SJ, Lundy DC. Ocular manifestations of autoimmune disease. Am Fam Physician. 2002;66:991-998.
3. Fujita M, Igarashi T, Sakane M, Yoshino S, Takahashi H. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol. 2005;140(5):808-813.
4. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
5. Williams DL. Analysis of tear uptake by the Schirmer tear test strip in the canine eye. Vet Ophthalmol. 2005;8(5):325-330.
6. Zhao J, Manthorpe R, Wollmer P. Surface activity of tear fluid in patients with primary Sjögren's syndrome. Clin Physiol Funct Imaging. 2002;22(1):24-27.
7. McMonnies C, Ho A, Wakefield D. Optimum dry eye classification using questionnaire responses. Adv Exp Med Biol. 1998;438:835-838.
8. Zhang M, Chen JQ, Liu ZG, et al. Zhonghua Yan Ke Za Zhi. Clinical characteristics of patients with dry eye syndrome. 2003;39(1):5-9.
9. Hikichi T, Yoshida A, Fukui Y, et al. Prevalence of dry eye in Japanese centers. Graefes Arch Clin Exp Ophthalmol. 1995;233:555-558.
10. Schaumber DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-326.
11. Moss SE, Klein R, Klein BEK. Incidence of dry eye in an older population. Arch Ophthalmol. 2004;122:369-373.
12. Jabs D. Ocular manifestations of rheumatic diseases. Philadelphia: JB Lippincott, 1992;1-5.
13. Lansbury J. Quantitation of the activity of rheumatoid arthritis. I. A method for recording its systemic manifestations. Am J Med Sci. 1956;231:616-621.
14. Mody GM, Hill JC, Meyers OL. Keratoconjunctivitis sicca in rheumatoid arthritis. Clin Rheumatol. 1988;7:237-241.
15. Ausayakhun S, Louthrenoo W, Aupapong S. Ocular diseases in patients with rheumatic diseases. J Med Assoc Thai. 2002;85:855-862.
16. Lopez Garcia JS, Garcia Loranzo I, Smaranda A, Martinez-Garchitorena J. But and Schirmer test comparative study in relation to dry eye etiology and severity. Arch Soc Esp Oftalmol. 2005;80(5):289-295.
17. Jones DT, Monroy D, Ji Z, Pflugfelder SC. Alterations of ocular surface gene expression in Sjoegren's syndrome. Adv Exp Med Biol. 1998;438:533-536.
18. Tishler M, Yaron I, Geyer O, et al. Elevated tear interleukin-6 levels in patients with Sjogren syndrome. Ophthalmology. 1998;105:2327-2329.
19. Solomon A, Dursun D, Lui Z, et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283-2292.
20. Prada J, Noelle B, Baatz H, Hartmann C, Pleyer U. Tumor necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations. Br J Ophthalmol. 2003;87:548-550.
21. Begley CG, Caffery B, Chalmers RL, Mitchell GL, Dry Eye Investigation (DREI) Study Group. Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. Cornea. 2002;21(7):664-670.
22. Nichols KK, Nichols JJ, Mitchell G.L. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23:762-770.
23. Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K. Meibomian gland dysfunction in patients of Sjogren syndrome. Ophthalmology. 1998;105(8):1485- 1488.
24. Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on human meibomian gland function and the ocular surface. J Clin Endocrinol Metab. 2000;85(12):4874-4882.
25. Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology. 1993;100(3):347-351.
26. Kujawa A, Rozycki R. Immunological phenomena in the pathology of the tear film. Is cyclosporine the turn point in Sjogren's syndrome treatment? Preliminary report. Klin Oczna. 2004;106(3 Suppl):489-491.
27. Baudouin C. The pathology of dry eye. Surv Ophthalmol. 2001;45(Suppl 2):S211-220.
28. Sendecka M, Baryluk A, Polz-Dacewicz M. Prevalence and risk factors of dry eye syndrome. Przegl Epidemiol. 2004;58(1):227-233.
29. Horwath-Winter J, Berghold A, Schmut O, et al. Evaluation of the clinical course of dry eye syndrome. Arch Ophthalmol. 2003;121(10):1364-1368.
30. Mertzanis P, Albertz L, Rajagopalan K, et al. The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci. 2005;46(1):46-50.